Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies
about
Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.Characterization of HCV genotype 5a envelope proteins: implications for vaccine development and therapeutic entry target.Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine developmentDevelopment of global consensus sequence of HCV glycoproteins involved in viral entry.
P2860
Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies
@ast
Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies
@en
type
label
Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies
@ast
Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies
@en
prefLabel
Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies
@ast
Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies
@en
P2093
P2860
P356
P1476
Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies
@en
P2093
Muhammad Qasim
Muhammad Tariq Awan
Muhammad Z Yousaf
Shah Jahan
Usman A Ashfaq
P2860
P2888
P356
10.1186/1479-5876-9-194
P577
2011-11-10T00:00:00Z
P5875
P6179
1021816578